FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32905511000001106: Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100386301000001115 Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100386401000001111 Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register Exempt Safe Custody) true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction special true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Is a Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules 1 ampoule true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has AMP Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has specific active ingredient Midazolam hydrochloride true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Midazolam 20mg/0.5ml / Lidocaine 10mg/0.5ml nasal solution ampoules (Special Order) 1 ampoule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start